Patient Capital Management·CIK 1854794
40
Positions
$2.2B
Portfolio Value
17
Quarters tracked
Q4 2025
Latest filing
Portfolio Allocation — Q2 2025
Portfolio Value Over Time
| 3 | NFE | 1.06% | $20,632,071 | SOLD |
| 4 | ET | 3.34% | $73,904,328 | ▼ -1.3% |
| 5 | MAT | 1.30% | $28,877,928 | ▼ -1% |
| 6 | AMZN | 5.58% | $123,622,322 | ▼ -0% |
| 7 | BABA | 2.55% | $56,604,098 | ▼ -1.1% |
| 8 | GOOS | 0.37% | $8,229,887 | ▼ -0.7% |
| 9 | IAC | 2.93% | $64,934,485 | ▼ -1% |
| 10 | CVNA | 0.51% | $9,894,083 | SOLD |
| 11 | KOS | 1.50% | $33,264,314 | ▼ -0.6% |
| 12 | JD | 1.16% | $25,757,119 | ▼ -0.5% |
| 13 | OMF | 2.66% | $58,852,576 | ▼ -0% |
| 14 | CVS | 3.87% | $85,667,945 | ▼ -0.8% |
| 15 | CROX | 2.30% | $50,982,102 | ▼ -0.5% |
| 16 | UBS | 2.96% | $65,530,949 | ▼ -0.3% |
| 17 | PGEN | 1.04% | $23,101,613 | ▼ -0.3% |
| 18 | EXPE | 1.99% | $44,169,707 | ▼ -0.4% |
| 19 | PTON | 0.84% | $18,667,321 | ▼ -0.1% |
| 20 | BRLT | 0.01% | $158,000 | SOLD |
| 21 | LENB | 0.06% | $1,315,625 | ▼ -0% |